Preventing malaria in children in Busia, Uganda
Treatments studied
Part of Infections clinical trials.
This study tests if adding malaria prevention medicine to a vaccine schedule can better protect children from malaria. It is for healthy children living in Busia District, Uganda.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You live in Busia District, Uganda.
- You can attend the study clinic for fevers or other illnesses.
- You agree to avoid non-study medications when possible.
- Your child does not have sickle cell disease.
- Your child's biological mother is HIV-negative.
- Your child has no serious ongoing medical condition needing frequent care.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if giving two malaria medicines together (dihydroartemisinin piperaquine and primaquine) to everyone in a community can help reduce malaria. It is for people living in high-risk areas in eastern Ghana.
This study tests a new long-acting malaria prevention injection (MMV371) in healthy adults and adolescents in Rwanda. Researchers will monitor how safe it is and how your body processes it over 24 weeks.
This trial tests a new combination of experimental malaria vaccines to see if they are safe and help protect against malaria. It includes both adults and young children in malaria-affected areas.
This Phase 1/2 study tests a new vaccine meant to protect young children against malaria. If you qualify, your baby would get the study vaccine and be followed for about 12 months to check safety and early signs of protection.
This trial tests whether giving a malaria prevention drug (DHA-PQP) to pregnant women in Kasese District can reduce malaria in pregnancy. Pregnant women at Bugoye Health Center who are less than 22 weeks along may join.
This study aims to find the best way to treat or prevent malaria in children with HIV. It may also help children without HIV who live in areas where malaria is common.
Hear when a new Malaria Falciparum trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.